We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BZYR market cap is 6.56M. The company's latest EPS is USD -0.0102 and P/E is -4.90.
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.64M | -1.3M | -977k | -916k | -1.34M |
| Net Income | -1.63M | -1.2M | -977k | -916k | -1.34M |
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20k | 1,000 | 4k | 2k | 2k |
| Total Liabilities | 173k | 47k | 3k | 16k | 27k |
| Total Equity | -153k | -46k | 1,000 | -14k | -25k |
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -530k | -394k | -326k | -249k | -524k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 529k | 394k | 328k | 247k | 524k |
| Market Cap | 6.56M |
| Price to Earnings Ratio | -4.90 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -262.9 |
| Dividend Yield | - |
| Shares Outstanding | 131.45M |
| Average Volume (1 week) | 4.77k |
| Average Volume (1 Month) | 2.53k |
| 52 Week Change | 13.41% |
| 52 Week High | 0.077 |
| 52 Week Low | 0.013 |
| Spread (Intraday) | 0.02 (38%) |
| Company Name | Burzynski Research Institute (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.burzynskiresearch.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
